Successful Early Neovascularization in Composite Tracheal Grafts
Otolaryngology–Head and Neck Surgery · 2023
DOI: 10.1002/ohn.350 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2023. Verfasst von Sarah C Nyirjesy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head & Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Trachea, Plastic Surgery Procedures. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Objective
Long‐segment tracheal defects require tissue replacement for successful reconstruction. Rapid revascularization is imperative to maintain graft function. We previously showed that partially decellularized tracheal grafts (PDTG) and composite tracheal grafts (CTG; PDTG supported by a 3‐dimensionally printed external splint) regenerate respiratory epithelium and may support the regeneration of endothelial cells (CD31+). However, the capability of graft endothelial cells to organize or contribute to tracheal revascularization remains unclear. In this study, we quantified endothelial cells (CD31+) and neovessel formation in PDTG and CTG. We hypothesize that PDTG and CTG support tracheal neovascularization to a similar extent as surgical (syngeneic tracheal graft [STG]) and native trachea (NT) controls. Study Design The animal study, a randomized control trial.
Setting
Center for Regenerative Medicine, Nationwide Children's Hospital.
Methods
PDTG was created via an established decellularization protocol. Segmental tracheal reconstruction was performed with STG, PDTG, or CTG using a mouse microsurgical model. NT was used as a nonsurgical control. At 1 month, mice were euthanized, grafts harvested, sectioned, and stained with CD31 and hematoxylin and eosin. Neovessel formation was quantified by the number of formed blood vessels in the lamina propria and vessel size (vessel/graft area, mm 2 ).
Results
Decellularization eliminated all endothelial cells and there were no perfused vessels at implantation. At 1 month, PDTG and CTG supported neovessel formation with tubular vessels lined with endothelial cells. There was no difference in the number or size of vessels compared to controls.
Conclusion
PDTG and CTG support tracheal endothelial cell regeneration and neovessel formation. Future directions to assess the function, kinetics, and distribution of graft neovessels are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head & Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
- Center of Regenerative Medicine, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio, USA.
- Department of Pediatric Otolaryngology, Nationwide Children's Hospital, Columbus, Ohio, USA.
ORCID-Profile: Sarah C Nyirjesy
Förderung
- NHLBI NIH HHS
Zitieren
APA
Nyirjesy, S. C., Yu, J., Dharmadhikari, S., Liu, L., Bergman, M., Tan, Z. H., VanKoevering, K. K., & Chiang, T. (2023). Successful Early Neovascularization in Composite Tracheal Grafts. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.350
Vancouver
Nyirjesy SC, Yu J, Dharmadhikari S, Liu L, Bergman M, Tan ZH, et al. Successful Early Neovascularization in Composite Tracheal Grafts. Otolaryngology–Head and Neck Surgery. 2023. doi:10.1002/ohn.350
BibTeX
@article{Nyirjesy2023,
author = {Nyirjesy, Sarah C and Yu, Jane and Dharmadhikari, Sayali and Liu, Lumei and Bergman, Maxwell and Tan, Zheng Hong and VanKoevering, Kyle K and Chiang, Tendy},
title = {Successful Early Neovascularization in Composite Tracheal Grafts},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2023},
doi = {10.1002/ohn.350}
}
EUVIMED